ISRAEL KLEIN

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA)

- Issues relating to the 340B Drug Pricing Program - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Legislation to prevent and reduce prescription drug abuse. Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771). Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469).

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Legislation to prevent and reduce prescription drug abuse - Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies - Pharmaceutical compounding and implementation of the Drug Quality Security Act - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- General diabetes prevention - P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act - World Hemophilia Day - H. Res. 142 and S. Res. 63/S. Res. 325 (A resolution) expressing support for designation of the week of October 29 through November 4, 2017, as "National Obesity Care Week" - H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309/S. 920) - World Hemophilia Day - National Obesity Care Week (H. Res. 142/S. Res. 63) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309/S. 920) - World Hemophilia Day - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA)

- Issues relating to the 340B Drug Pricing Program - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309) - World Hemophilia Day - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Legislation to prevent and reduce prescription drug abuse - Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies - Pharmaceutical compounding and implementation of the Drug Quality Security Act - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program - Issues related to P.L. 115-52 (H.R. 2430/S. 934) - H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act - H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act

- Legislation to prevent and reduce prescription drug abuse - Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies - Pharmaceutical compounding and implementation of the Drug Quality Security Act - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Legislation to prevent and reduce prescription drug abuse. Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771). Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469).

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction). - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction). - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- H.R. 1953/S. 830 Treat and Reduce Obesity Act - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D - H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R.849/S. 260)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R. 849/S. 260)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program - Issues related to P.L. 115-52 (H.R. 2430/S. 934) - H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act - H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Preventive Health Savings Act (H.R. 2953) - National Diabetes Prevention Program in FY 2018 Labor, HHS & Education Appropriations

- Preventive Health Savings Act (H.R. 2953) - National Diabetes Prevention Program in FY 2018 Labor, HHS & Education Appropriations

- H.R. 2953/S. 2164 Preventative Health Savings Act (CBO scoring of preventive health) - National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309/S. 920) - World Hemophilia Day - National Obesity Care Week (H. Res. 142/S. Res. 63) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act

- General diabetes prevention - P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act - World Hemophilia Day - H. Res. 142 and S. Res. 63/S. Res. 325 (A resolution) expressing support for designation of the week of October 29 through November 4, 2017, as "National Obesity Care Week" - H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309/S. 920) - World Hemophilia Day - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309) - World Hemophilia Day - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

- H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program - Issues related to P.L. 115-52 (H.R. 2430/S. 934) - H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act - H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act

- H.R. 1953/S. 830 Treat and Reduce Obesity Act - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D - H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R.849/S. 260)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R. 849/S. 260)

- H.R. 960, S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

H.R. 960 / S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

- General diabetes prevention - P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act - World Hemophilia Day - H. Res. 142 and S. Res. 63/S. Res. 325 (A resolution) expressing support for designation of the week of October 29 through November 4, 2017, as "National Obesity Care Week" - H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017

- Issues related to diabetes screening and prevention - Clinical Care Commission Act (H.R. 309/S. 920) - World Hemophilia Day - National Obesity Care Week (H. Res. 142/S. Res. 63) - American Health Care Act (H.R. 1628) and Better Care Reconciliation Act

- H.R. 2953/S. 2164 Preventative Health Savings Act (CBO scoring of preventive health) - National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations)

- H.R. 960, S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

H.R. 960 / S. 236 - Public Building Renewal Act

- H.R. 960, S. 236 - Public Building Renewal Act

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R.849/S. 260)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R. 849/S. 260)

- H.R. 1953/S. 830 Treat and Reduce Obesity Act - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D - H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R.849/S. 260)

- Treat and Reduce Obesity Act (H.R. 1953/S. 830) - Issues related to the Medicare Diabetes Prevention Program and self-management education - Issues related to Medicare Part D - IPAB repeal, including the Protecting Medicare from Executive Action Act (S. 251) and Protecting Seniors' Access to Medicare Act (H.R. 849/S. 260)

- H.R. 1953/S. 830 Treat and Reduce Obesity Act - Medicare Diabetes Prevention Program; diabetes self-management education - Issues related to Medicare Part D - H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction). - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP) (H.R. 1920); ASP, generally (in the context of Deficit Reduction) - Legislation to exclude cancer drugs from sequestration cuts; Cancer Care Payment Reform Act (H.R. 1834/S. 463)

- Issues relating to the 340B Drug Pricing Program - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Issues related to biosimilars, generally - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Legislation to prevent and reduce prescription drug abuse. Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and implementation of the Drug Quality Security Act. Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771). Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469).

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- Legislation to prevent and reduce prescription drug abuse - Legislation to prohibit prescription drug plan sponsors and MA-PD organizations under Medicare from retroactively reducing payment on clean claims submitted by pharmacies - Pharmaceutical compounding and implementation of the Drug Quality Security Act - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

- H.R. 4710, the 340B Protecting Access for the Underserved and Safety-Net Entities Act (340 PAUSE Act)and other issues related to 340B program - Issues related to P.L. 115-52 (H.R. 2430/S. 934) - H.R. 1776/S.771 Improving Access To Affordable Prescription Drugs Act - H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act

- Prescription opioid-related issues - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469) - Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drugs Act (S. 771) - Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)

- Issues relating to the 340B Drug Pricing Program - FDA Reauthorization Act (H.R. 2430/S. 934) - Improving Access to Affordable Prescription Drug Act (H.R. 1776/S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)